Correction: Precision synbiotic intervention with 2'-fucosyllactose and infant-derived <i>Bifidobacterium</i> modulates gut-immune axis and reduces disease risk in toddlers: a randomized controlled trial. [PDF]
Chen K +15 more
europepmc +1 more source
2'-Fucosyllactose modulates gut microbiota and systemic metabolism in mild-to-moderate ulcerative colitis: a randomized crossover trial. [PDF]
Kennedy JM +5 more
europepmc +1 more source
Exploring the effect of tandem non-native non-F-type lectin carbohydrate-binding domains on <i>Streptosporangium roseum</i> α-L-Fucosidase activity. [PDF]
Shivangi +3 more
europepmc +1 more source
Aryl Hydrocarbon Receptor Deficiency Impairs Intestinal Barrier Development, While 2'-Fucosyllactose Reduces Paracellular Permeability in Caco-2 Cells. [PDF]
Madella AM +6 more
europepmc +1 more source
Correction to "Multi-level metabolic engineering of Escherichia coli for high-titre biosynthesis of 2'-fucosyllactose and 3-fucosyllactose". [PDF]
europepmc +1 more source
Modulation of the gut microbiome and resistome by antibiotic use, but not by subsequent 2'-fucosyllactose intake, in adults with overweight or obesity. [PDF]
Vliex LMM +4 more
europepmc +1 more source
An exploratory analysis of the associations of human milk oligosaccharides and N-/O-glycans with infectious and allergic outcomes in the first year of life: the Japanese Human Milk Study Cohort. [PDF]
Tsujimori Y +6 more
europepmc +1 more source
Metabolization of human milk oligosaccharides by Streptococcus pneumoniae. [PDF]
Bacher K +15 more
europepmc +1 more source
Identification of a Novel Fungal α‑l‑Fucosidase with Transfucosylation Potential. [PDF]
Nekvasilová P +5 more
europepmc +1 more source

